Clinical Trials Logo

Immune Response To Sepsis clinical trials

View clinical trials related to Immune Response To Sepsis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01879761 Active, not recruiting - Clinical trials for Staphylococcus Aureus Infection

Immune Resolution After Staphylococcus Aureus Bacteremia

Start date: June 2013
Phase:
Study type: Observational

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia. We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.